1. Home
  2. PT vs CARM Comparison

PT vs CARM Comparison

Compare PT & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • CARM
  • Stock Information
  • Founded
  • PT 2012
  • CARM 2016
  • Country
  • PT China
  • CARM United States
  • Employees
  • PT N/A
  • CARM N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • CARM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • CARM Health Care
  • Exchange
  • PT Nasdaq
  • CARM Nasdaq
  • Market Cap
  • PT 15.2M
  • CARM 12.2M
  • IPO Year
  • PT 2018
  • CARM N/A
  • Fundamental
  • Price
  • PT $0.95
  • CARM $0.40
  • Analyst Decision
  • PT
  • CARM Hold
  • Analyst Count
  • PT 0
  • CARM 5
  • Target Price
  • PT N/A
  • CARM $0.90
  • AVG Volume (30 Days)
  • PT 5.2K
  • CARM 25.2M
  • Earning Date
  • PT 11-07-2025
  • CARM 11-06-2025
  • Dividend Yield
  • PT N/A
  • CARM N/A
  • EPS Growth
  • PT N/A
  • CARM N/A
  • EPS
  • PT N/A
  • CARM N/A
  • Revenue
  • PT $4,814,566.00
  • CARM $10,767,000.00
  • Revenue This Year
  • PT N/A
  • CARM N/A
  • Revenue Next Year
  • PT N/A
  • CARM N/A
  • P/E Ratio
  • PT N/A
  • CARM N/A
  • Revenue Growth
  • PT N/A
  • CARM N/A
  • 52 Week Low
  • PT $0.76
  • CARM $0.14
  • 52 Week High
  • PT $1.15
  • CARM $1.27
  • Technical
  • Relative Strength Index (RSI)
  • PT 48.66
  • CARM 60.37
  • Support Level
  • PT $0.98
  • CARM $0.21
  • Resistance Level
  • PT $0.98
  • CARM $0.56
  • Average True Range (ATR)
  • PT 0.03
  • CARM 0.05
  • MACD
  • PT -0.00
  • CARM 0.02
  • Stochastic Oscillator
  • PT 18.18
  • CARM 55.46

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

Share on Social Networks: